Skip to main content
Article thumbnail
Location of Repository

Chemokine receptor expression in tumour islets and stroma in non-small cell lung cancer

By Chandra M. Ohri, Aarti Shikotra, Ruth H. Green, David A. Waller and Peter Bradding


Background: We have previously demonstrated that tumour islet infiltration by macrophages is associated with extended survival (ES) in NSCLC. We therefore hypothesised that patients with improved survival would have high tumour islet expression of chemokine receptors known to be associated with favourable prognosis in cancer. This study investigated chemokine receptor expression in the tumour islets and stroma in NSCLC.\ud Methods: We used immunohistochemistry to identify cells expressing CXCR1, CXCR2, CXCR3, CXCR4, CXCR5 and CCR1 in the tumour islets and stroma in 20 patients with surgically resected NSCLC. Correlations were made with macrophage and mast cell expression.\ud Results: There was increased expression of CXCR2, CXCR3, and CCR1 in the tumour islets of ES compared with poor survival (PS) patients (p = 0.007, 0.01, and 0.002, respectively). There was an association between 5 year survival and tumour islet CXCR2, CXCR3 and CCR1 density (p = 0.02, 0.003 and <0.001, respectively) as well as stromal CXCR3 density (p = 0.003). There was a positive correlation between macrophage density and CXCR3 expression (r[subscript s] = 0.520, p = 0.02) and between mast cell density and CXCR3 expression (r[subscript s] = 0.499, p = 0.03) in the tumour islets.\ud Conclusion: Above median expression of CXCR2, CXCR3 and CCR1 in the tumour islets is associated with increased survival in NSCLC, and expression of CXCR3 correlates with increased macrophage and mast cell infiltration in the tumour islets.Peer-reviewedPublisher Versio

Publisher: BioMed Central Ltd
Year: 2010
DOI identifier: 10.1186/1471-2407-10-172
OAI identifier:

Suggested articles


  1. (2005). Bradding P: Differential expression of CCR3 and CXCR3 by human lung and bone marrow-derived mast cells: implications for tissue mast cell migration. doi
  2. (2009). Bradding P: Macrophages within NSCLC tumour islets are predominantly of a cytotoxic M1 phenotype associated with extended survival. Eur Respir J doi
  3. (2004). Cancer and the chemokine network. Nat Rev Cancer doi
  4. (2008). Cerwenka A: Natural Killer Cell Accumulation doi
  5. (2004). Depletion of CXCR2 inhibits tumor growth and angiogenesis in a murine model of lung cancer. doi
  6. (1994). et al.: Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma.
  7. (2002). et al.: Prognostic significance of tumor infiltrating natural killer cells subset CD57 in patients with squamous cell lung cancer. Lung Cancer doi
  8. Funding for this study was provided by the James Maxwell Grant Prophit Fellowship awarded to Dr Chandra Ohri by the Royal College of Physicians, London, United Kingdom. Author Details 1Department of Infection,
  9. (2008). H: Th1/Th2 cytokines reciprocally regulate in vitro pulmonary angiogenesis via CXC chemokine synthesis. doi
  10. (1996). Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases. doi
  11. (2000). Interleukin-8 Messenger Ribonucleic Acid Expression Correlates with Tumor Progression, Tumor Angiogenesis, Patient Survival, and Timing of Relapse in Non-Small-Cell Lung Cancer. Am J Respir Crit Care Med doi
  12. (2009). JA: T cell extravasation: demonstration of synergy between activation of CXCR3 and the T cell receptor. Mol Immunol doi
  13. (2005). Macrophage and mast-cell invasion of tumor cell islets confers a marked survival advantage in non-small-cell lung cancer. doi
  14. (2000). Macrophage infiltration in human non-small-cell lung cancer: the role of CC chemokines. Cancer Immunol Immunother doi
  15. (2008). Mantovani A: Pathways connecting inflammation and cancer. Curr Opin Genet Dev doi
  16. (2004). PJ: Interleukin-8/CXCL8 is a growth factor for human lung cancer cells. doi
  17. (2002). RANTES Expression Is a Predictor of Survival in Stage I Lung Adenocarcinoma. Clin Cancer Res
  18. (2009). RM: CXCR4 expression on circulating pan-cytokeratin positive cells is associated with survival in patients with advanced non-small cell lung cancer. doi
  19. (2004). The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol doi
  20. (2000). The CXC chemokine, monokine induced by interferon-gamma, inhibits non-small cell lung carcinoma tumor growth and metastasis. Hum Gene Ther doi
  21. (2001). The intratumoral expression of vascular endothelial growth factor and interleukin-8 associated with angiogenesis in nonsmall cell lung carcinoma patients. Cancer doi
  22. (2001). The prognostic value of natural killer cell infiltration in resected pulmonary adenocarcinoma. J Thorac Cardiovasc Surg doi
  23. (2003). The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases. Am J Respir Crit Care Med doi
  24. (2000). Zlotnik A: The Biology of Chemokines and their Receptors. Annual Review of Immunology doi

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.